quant Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 17.5096 ↓ -1.44%
[as on 23 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan and its peers as on 23 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
quant Healthcare Fund - Growth Option - Direct Plan 12.41% -1.44% -3.55% -10.18% -1.05% 8.56% 19.06%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -16.54% -1.48% -5.29% -9.11% -11.17% -19.02% 2.82% 8.83% 12.59% 12.7%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -9.94% -1.12% -3.18% -5.3% -5.96% -9.41% 7.81% 6.19% 11.42% 10.93%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 13.24% -0.89% -2.7% -10.24% -4.98% 8.45% 21.84% 17.41% 24.31% 13.86%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH -6.32% -1.44% -3.94% -6.98% -8.87% -5.52% 10.86% 13.9% 17.66% 14.1%
SBI COMMA Fund - DIRECT PLAN - Growth -2.89% -1.79% -4% -9.12% -6.97% 0.61% 13.65% 8.79% 16.81% 13.73%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 32.34% -4.87%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.78% -5.07% 2.58% -5.34% 6.23% 5.07% 6.57% 2.82% 5.93% -2.83%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 0.92%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
70.33% 5.57% (Arbitrage: 0.00%) 0.00% 0.00% -4.55%

Equity

NameSymbol / ISINSectorWeight %Other links
Glaxosmithkline Pharmaceuticals LtdGLAXO (INE159A01016)Pharmaceuticals & Biotechnology10.58%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology9.30%
Pfizer LtdPFIZER (INE182A01018)Pharmaceuticals & Biotechnology8.83%
Alivus Life SciencesALIVUS (INE03Q201024)Pharmaceuticals & Biotechnology8.08%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology7.03%
SMS Pharmaceuticals LimitedSMSPHARMA (INE812G01025)Pharmaceuticals & Biotechnology6.71%
IPCA Laboratories LtdIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology6.22%
Zydus Wellness LtdZYDUSWELL (INE768C01028)Food Products5.64%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology5.18%
Strides Pharma Science LtdSTAR (INE939A01011)Pharmaceuticals & Biotechnology2.45%
Sumitomo Chemical India LimitedSUMICHEM (INE258G01013)Fertilizers & Agrochemicals0.31%

Debt

NameIsinRatingWeight %Yield
91 Days Treasury Bill 03-Sep-2026IN002026X099N.A.0.70%5.20%
91 Days Treasury Bill 10-Sep-2026IN002026X107N.A.0.70%5.18%
91 Days Treasury Bill 17-Sep-2026IN002026X115N.A.0.70%5.00%
91 Days Treasury Bill 15-Oct-2026IN002026X156N.A.0.70%5.11%
91 Days Treasury Bill 22-Oct-2026IN002026X164N.A.0.70%5.10%
91 Days Treasury Bill 05-Nov-2026IN002026X180N.A.0.69%5.25%
91 Days Treasury Bill 19-Nov-2026IN002026X206N.A.0.69%5.26%
91 Days Treasury Bill 27-Nov-2026IN002026X214N.A.0.69%5.27%
Portfolio data is as on date 31 August, 2026

NAV history

quant Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
23 October, 202617.5096 -1.44%
22 October, 202617.7659 -0.25%
21 October, 202617.81 -0.72%
19 October, 202617.9383 -1.19%
16 October, 202618.1549 -0.64%
15 October, 202618.2715 -0.41%
14 October, 202618.3464 -0.91%
13 October, 202618.5141 0.37%
12 October, 202618.4455 0.35%
9 October, 202618.3807 0.91%
8 October, 202618.2141 -2.33%
7 October, 202618.6491 -0.82%
6 October, 202618.8031 1.11%
5 October, 202618.5959 -0.51%
1 October, 202618.6912 -0.9%
30 September, 202618.8601 -1.61%
29 September, 202619.1687 -0.13%
28 September, 202619.1938 -0.59%
25 September, 202619.3068 -0.38%
24 September, 202619.3809 -0.58%
23 September, 202619.4933 0.83%
22 September, 202619.3326 -0.62%
21 September, 202619.4526 0.55%
18 September, 202619.3469 0.81%
17 September, 202619.1917 0.78%
16 September, 202619.0437 0.65%
15 September, 202618.9203 -1.55%
11 September, 202619.2174 -0.24%
10 September, 202619.2644 -0.35%
9 September, 202619.3319

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of quant Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of quant Healthcare Fund - Growth Option - Direct Plan is 17.5096 as on 23 October, 2026.
  • What are YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of quant Healthcare Fund - Growth Option - Direct Plan are 12.41% as on 23 October, 2026.
  • What are 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of quant Healthcare Fund - Growth Option - Direct Plan are 8.56% as on 23 October, 2026.
  • What are 3 year CAGR returns of quant Healthcare Fund - Growth Option - Direct Plan?
    The 3 year annualized returns (CAGR) of quant Healthcare Fund - Growth Option - Direct Plan are 19.06% as on 23 October, 2026.
  • What are top 10 holdings of quant Healthcare Fund - Growth Option - Direct Plan?
    Top 10 holdings of quant Healthcare Fund - Growth Option - Direct Plan are:
    • Glaxosmithkline Pharmaceuticals Ltd
    • Zydus Lifesciences Limited
    • Pfizer Ltd
    • Alivus Life Sciences
    • Concord Biotech Limited
    • SMS Pharmaceuticals Limited
    • IPCA Laboratories Ltd
    • Zydus Wellness Ltd
    • Aurobindo Pharma Limited
    • Strides Pharma Science Ltd
    • Sumitomo Chemical India Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for quant Healthcare Fund - Growth Option - Direct Plan?
    quant Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.